Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles

I-Mab Doses First Patient in Phase III Trial of Novel Growth Hormone Therapy
YishengBio Raises $130 Million for Immunomodulating Therapies
Bioelectronica Closes $16 Million Funding from China Investors
CanSino Files for China Approval of COVID-19 Vaccine
Clover Raises $230 Million for Trimer-Tag Vaccines (including COVID-19) and Cancer Therapies
Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021